Kriya Therapeutics Completes $100 Million Series B Financing To Advance Its Fully Integrated Platform For Designing, Developing And Manufacturing Transformative Gene Therapies
Amount Raised
$100 Million
Round Type
Series B
MorrisvilleBiotechnologyresearchDescription
Kriya Therapeutics, Inc., a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy, today announced the closing of a $100 Million Series B financing to support its mission of transforming the design, development and manufacturing of gene therapies.
Quick answer
Kriya Therapeutics raised $100 Million in a Series B round, dated July 14, 2021. Kriya Therapeutics is based in Morrisville, North Carolina, United States.
- How much did Kriya Therapeutics raise?
- Kriya Therapeutics raised $100 Million in a Series B round on July 14, 2021.
- What does Kriya Therapeutics do?
- Kriya is a biopharmaceutical company on a mission to revolutionize medicine by developing gene therapies that aim to eliminate human suffering and free people from the burden of chronic disease.
- Where is Kriya Therapeutics based and how big is it?
- Kriya Therapeutics is based in Morrisville, North Carolina, United States. Fundz records about 190 employees.
- Who are the decision-makers at Kriya Therapeutics?
- Fundz holds 2 contacts at Kriya Therapeutics, including the Chief Regulatory Officer at Kriya Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in research and Biotechnology around the same time
Companies in the same sectors as Kriya Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Linnaeus Therapeutics raised $4.3M (Seed) on August 24, 2021.
- Wugen raised $37M on July 23, 2021.
- Wugen raised $99M on July 23, 2021.
- Akari Therapeutics raised $12M on July 22, 2021.
- Arzeda raised $26M on July 22, 2021.
- Wugen raised $172M (Funding Round) on July 15, 2021.
Who to call at Kriya Therapeutics, and when
A new round usually means Kriya Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kriya Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kriya Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kriya Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kriya Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansKriya Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.